Skip to main content
COVID-19 is an emerging, rapidly evolving situation.
Get the latest information from
CDC (coronavirus.gov)
|
NIH Resources
|
NIDA Resources
National Institutes of Health
Order Publications
En español
Search Component
Home
Drug Topics
Drug Topics
Alcohol
Club Drugs
Cocaine
Fentanyl
Hallucinogens
Heroin
Inhalants
Kratom
Marijuana
MDMA (Ecstasy/Molly)
Methamphetamine
Opioids
Over-the-Counter Medicines
Prescription Medicines
Steroids (Anabolic)
Synthetic Cannabinoids (K2/Spice)
Synthetic Cathinones (Bath Salts)
Tobacco/Nicotine and Vaping
More Drug Topics
Quick Links
COVID-19
Opioid Crisis
Commonly Used Drugs Chart
Emerging Trends
Fentanyl
NIDA Publications
Research & Training
Research & Training
NIDA Research Programs & Activities
Clinical Research
NIH Policies & Guidance
Research Data, Measures, & Resources
Research Training & Career Development
Resources for Grants & Contracts
Quick Links
HEAL Initiative
NIDA Drug Supply Program
Clinical Trials Stewardship
Fellowships & Grants
NIDA Notice of Special Interest (NOSI)
Clinical Resources
NIDAMED: Clinical Resources
For Your Discipline
Health Professions Education
Marijuana and Other Drugs
Opioid Crisis and Pain Management
Screening Tools & Prevention
Treatment
Quick Links
COVID-19 Resources
Grants & Funding
Grants & Funding
Contracts and Small Businesses
NIDA Funding Opportunities
Trans-NIH Funding Opportunities
Quick Links
Grants Address OUD in Criminal Justice Settings
Peer Review
Grant Application Forms
Grants & Contract Application Process
NIDA Notice of Special Interest (NOSI)
News & Events
News
News Releases
Nora's Blog
NIDA Notes
Research Highlights
Public Education Projects
NIDA in the News
Subject Area Experts
Quick Links
NIDA TV
NIDA Media Guide
Contact the Press Office
Meetings & Events
About NIDA
About NIDA
Advisory Boards and Review Groups
Director's Page
Legislative Activities
Organization
Working at NIDA
Quick Links
NIDA Strategic Plan
FY 2021 Budget Information
Clinical Trials Network
Contact Us
Breadcrumb
Home
About NIDA
Organization
Center for Clinical Trials Network (CCTN)
Clinical Trials Network (CTN)
Research Studies
Protocol
Number
Status
Examining the COVID-19 Public Health Emergency on Policy, Substance Use Disorder, Treatment and Resilience among American Indian and Alaska Native Communities
CTN-0118
Development
The Impact of COVID-19 Pandemic on Substance Use Treatment Services
CTN-0117
Development
Pharmacist-Integrated Model of Medication Treatment for Opioid Use Disorder
CTN-0116
Development
Developing an Intervention to Address Intersecting Prescription Opioid and Chronic Pain Stigma in Cancer Survivors (NIH HEAL Initiative)
CTN-0115
Development
Drug Repurposing for Cocaine Use Disorder (CUD) Using a Combined Strategy of Artificial Intelligence (AI)-Based Prediction and Retrospective Clinical Corroboration
CTN-0114
Development
Validating a DSM-5 Substance Use Disorder (SUD) Symptom Checklist in EHR Data from a Large Primary Care Sample to Support Future Pragmatic Trials and Chronic Care Management of SUDs in Primary Care
CTN-0113
Development
Optimal Policies to Improve Methadone Maintenance Adherence Longterm (OPTIMMAL)
CTN-0112
Development
COVID-19 and Substance Misuse Case Identification using Data Science: A Retrospective Cohort Study
CTN-0111
Development
Randomized, Double-Blind, Placebo-Controlled Trial of Monthly Injectable Buprenorphine for Methamphetamine Use Disorder (MURB)
CTN-0110
Development
Randomized, Placebo-Controlled Trial of Injectable Naltrexone and Monthly Injectable Buprenorphine for Cocaine Use Disorder (CURB-2)
CTN-0109
Development
Transcranial Magnetic Stimulation for the Treatment of Methamphetamine/Cocaine Use Disorder
CTN-0108
Development
Peer recovery Support: A Bridge to Treatment for Overdose Survivors (NIH HEAL Initiative)
CTN-0107
Development
Derivation and Validation of New Measurement-Based Care Tools Derived from the Brief Addiction Monitor (NIH HEAL Initiative)
CTN-0106
Active
Integrating pharmacy-based prevention and treatment of opioid and other substance use disorders: A survey of pharmacists and stakeholder (NIH HEAL Initiative)
CTN-0105
Development
Healthcare Provider Stigma Related to the Opioid Use Epidemic and its Impact on Patient Treatment and Clinical Management
CTN-0104
Active
Expanding Clinical Research Training on Implementing the Evidence-based Hub and Spoke Model of Medication-Assisted Treatment for Opioid Use Disorder (NIH HEAL Initiative)
CTN-0103
Completed
Rural Expansion of Medication Treatment for Opioid Use Disorder (NIH HEAL Initiative)
CTN-0102
Active
Subthreshold Opioid Use Disorder Prevention (STOP) Trial (NIH HEAL Initiative)
CTN-0101
Active
Optimizing Retention, Duration, and Discontinuation Strategies for Opioid Use Disorder Pharmacotherapy (NIH HEAL Initiative)
CTN-0100
Development
Emergency Department-INitiated bupreNOrphine and VAlidaTIOn Network Trial (ED-INNOVATION) (NIH HEAL Initiative)
CTN-0099
Active
Exemplar Hospital Initiation Trial to Enhance Treatment Engagement (EXHIT ENTRE) (NIH HEAL Initiative)
CTN-0098
Development
Surmounting Withdrawal to Initiate Fast Treatment with Naltrexone (SWIFT): Improving the Real-World Effectiveness of Injection Naltrexone for Opioid Use Disorder (NIH HEAL Initiative)
CTN-0097
Development
Culturally Centered MAT for OUD Implementation Facilitation for Primary Care and Addiction Treatment Programs Serving American Indian/Alaska Natives (NIH HEAL Initiative)
CTN-0096
Active
Reducing Stigma Toward People with Opioid Use Disorder Among Primary Care Clinicians (NIH HEAL Initiative)
CTN-0095-A-2
Development
Suicide Prediction and Prevention for People at Risk for Opioid Use Disorder (NIH HEAL Initiative)
CTN-0095-A-1
Development
Clinic-Randomized Trial of Clinical Decision Support for Opioid Use Disorders in Medical Settings (NIH HEAL Initiative)
CTN-0095
Active
Individual Level Predictive Modeling of Opioid Use Disorder Treatment Outcome (NIH HEAL Initiative)
CTN-0094
Active
Validation of a Community Pharmacy-based Prescription Drug Monitoring Program Risk Screening Tool (PHARMSCREEN) (NIH HEAL Initiative)
CTN-0093
Completed
Preventing and Identifying Opioid Use Disorder using the Six Building Blocks (6BBs) for Improving Opioid Prescription Management (NIH HEAL Initiative)
CTN-0091
Completed
Innovatively Increasing PCP Prescribing of Buprenorphine: Measurement Based Care and Integrated Electronic Solution (NIH HEAL Initiative)
CTN-0090
Completed
Integrating Nurse Practitioner Buprenorphine Waiver Training into Graduate Nursing Curriculum (NIH HEAL Initiative)
CTN-0089
Completed
DC Research Infrastructure Building & Initiative to Reach, Engage, and Retain in MAT patients with OUD (NIH HEAL Initiative)
CTN-0088
Active
A Foundation to Examine Reasons for Discontinuation for Buprenorphine Care in the Veterans Health Administration (NIH HEAL Initiative)
CTN-0087
Completed
Inpatient versus Outpatient Treatment Outcomes for People with Opioid Use Disorder (NIH HEAL Initiative)
CTN-0086
Completed
Selection Bias-Free Estimation of the Impact of Drug-Focused 12-step Mutual Help Groups (NIH HEAL Initiative)
CTN-0085
Completed
Developing a Prescription Opioid Registry across Diverse Health Systems (NIH HEAL Initiative)
CTN-0084
Active
Using Social Media to Deliver HIV Self-Testing Kits and Link to Online PrEP Services
CTN-0083
Completed
Implementation Survey of PrEP and Opioid Use Related Services in STI Clinics and MSM-Centered Community Based Organizations (CBOs)
CTN-0082
Active
Emergency Medicine Opioid Data Infrastructure: Key Venue to Address Opioid Morbidity and Mortality (Project CODE PRO – Capturing Opioid Use Disorder Electronically and Patient Reported Outcomes)
CTN-0081
Completed
Medication Treatment for Opioid-dependent Expecting Mothers (MOMs): A Pragmatic Randomized Trial Comparing Two Buprenorphine Formulations
CTN-0080
Active
Emergency Department Connection to Care with Buprenorphine for Opioid Use Disorder (ED-CONNECT)
CTN-0079
Completed
Knowledge of and Attitudes about Medication Assisted Treatment within American Indian Communities
CTN-0078
Active
Medical Cannabis Use among Primary Care Patients: Using Electronic Health Records to Study Large Populations
CTN-0077
Completed
Clinical decision support for Opioid use disorders in Medical settings: Pilot Usability Testing in an EMR (COMPUTE)
CTN-0076
Completed
Pharmacy Screening and Collaborative Opioid Use Disorder Care (Pharm-OUD-Care)
CTN-0075
Completed
Primary Care Opioid Use Disorders Treatment Trial Economic Analysis Study (NIH HEAL Initiative)
CTN-0074-A-1
Active
Primary Care Opioid Use Disorders Treatment Trial
CTN-0074
Active
Towards Detecting Cocaine Use Using Smartwatches in the NIDA Clinical Trials Network
CTN-0073
Completed
Patient and System-Level Factors Associated with HEDIS AOD-IET Measure Performance across Health Systems
CTN-0072
Completed
Electronic Health Records Data Elements Research (EHR-DARE)
CTN-0071
Completed
Interpretation and Implementation of Title 42 CFR Part 2 for Confidentiality of Patient Drug and Alcohol Use Records: NIDA CTN Stakeholder Snapshot
CTN-0070
Completed
Opioid Use Disorder in the Emergency Department
CTN-0069
Completed
Accelerated Development of Additive Pharmacotherapy Treatment (ADAPT-2) for Methamphetamine Use Disorder
CTN-0068
Completed
Comparing Treatments for HIV-Positive Opioid Users in an Integrated Care Effectiveness Study (CHOICES); Scale-Up
CTN-0067
Completed
Opioid Use Disorders in Primary Care Settings: Linking EHRs with PDMP and National Death Index Data Systems
CTN-0066
Completed
Evaluation of Drug Screening Implementation in Primary Care
CTN-0065
Completed
Linkage to Hepatitis C Virus Care among HIV/HCV Co-infected Substance Users
CTN-0064
Completed
Gender Differences in the Interrelationships between Sexual Abuse, Risky Sexual Behavior, and Anxiety/Depression in Treatment Efficacy and Drug Use over Time among Individuals with Substance Use Disorders
CTN-0063
Completed
A Phased-Implementation Feasibility and Proof-of-Concept Study to Assess Incorporating the NIDA CTN Common Data Elements into the Electronic Health Record in Large Primary Care Settings
CTN-0062
Completed